(Q42965034)

11 November 2017

title

131I/123I-metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging (English)

1 reference

11 November 2017

1 reference

Lorenzo Stefano Maffioli

6

1 reference

11 November 2017

12

1 reference

11 November 2017

0 references

Emilio Bombardieri

1

1 reference

11 November 2017

Francesco Giammarile

2

1 reference

11 November 2017

Cumali Aktolun

3

1 reference

11 November 2017

Richard P Baum

4

1 reference

11 November 2017

Angelika Bischof Delaloye

5

1 reference

11 November 2017

Roy Moncayo

7

1 reference

11 November 2017

Luc Mortelmans

8

1 reference

11 November 2017

Giovanna Pepe

9

1 reference

11 November 2017

Sven N Reske

10

1 reference

11 November 2017

Maria R Castellani

11

1 reference

11 November 2017

European Association for Nuclear Medicine

13

1 reference

11 November 2017

publication date

1 December 2010

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

11 November 2017

published in

1 reference

11 November 2017

volume

37

1 reference

11 November 2017

issue

12

1 reference

11 November 2017

page(s)

2436-2446

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-010-1545-7

11 November 2017

exact match

0 references

cites work

Radioiodinated metaiodobenzylguanidine: a review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-010-1545-7

Pitfalls in scintigraphic detection of neuroendocrine tumours.

21 January 2018

1 reference

12 December 2020

Nuclear medicine imaging of pheochromocytoma and neuroblastoma

1 reference

12 December 2020

Routine quality control recommendations for nuclear medicine instrumentation

1 reference

12 December 2020

Guidelines for radioiodinated MIBG scintigraphy in children.

1 reference

12 December 2020

Combined diagnostic imaging with 131I-metaiodobenzylguanidine and 111In-pentetreotide in carcinoid tumours

1 reference

12 December 2020

Portrayal of pheochromocytoma and normal human adrenal medulla by m-[123I]iodobenzylguanidine: concise communication

1 reference

12 December 2020

Iodine-123-MIBG imaging of neuroblastoma: utility of SPECT and delayed imaging

1 reference

12 December 2020

Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues

1 reference

12 December 2020

Nuclear medicine imaging of neuroendocrine tumours

1 reference

12 December 2020

Clinical Impact and Prognostic Value of Metaiodobenzylguanidine Imaging in Children With Metastatic Neuroblastoma

1 reference

12 December 2020

[123I]MIBG scintigraphy in neuroblastoma: a comparison between planar and SPECT imaging

1 reference

12 December 2020

Treatment planning for 131I-mIBG radiotherapy of neural crest tumours using 124I-mIBG positron emission tomography

1 reference

12 December 2020

Radiochemistry, biochemistry, and kinetics of 131I-metaiodobenzylguanidine (MIBG) and 123I-MIBG: clinical implications of the use of 123I-MIBG.

1 reference

12 December 2020

Functional scintigraphy of the adrenal gland

1 reference

12 December 2020

A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG)

1 reference

12 December 2020

Scintigraphic response by 123I-metaiodobenzylguanidine scan correlates with event-free survival in high-risk neuroblastoma

1 reference

12 December 2020

The new EANM paediatric dosage card.

1 reference

12 December 2020

Evaluation of (111)In-pentetreotide, (131)I-MIBG and bone scintigraphy in the detection and clinical management of bone metastases in carcinoid disease

1 reference

12 December 2020

Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients

1 reference

12 December 2020

Nuclear medicine procedures and neuroblastoma in childhood. Their value in the diagnosis, staging and assessment of response to therapy

1 reference

12 December 2020

Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma.

1 reference

12 December 2020

Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans

1 reference

12 December 2020

The utility of metaiodobenzylguanidine single photon emission computed tomography/computed tomography (MIBG SPECT/CT) for the diagnosis of pheochromocytoma.

1 reference

12 December 2020

Specificity of radioiodinated MIBG for neural crest tumors in childhood

1 reference

12 December 2020

Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma

1 reference

12 December 2020

Dosimetry of pediatric nuclear medicine procedures

1 reference

12 December 2020

Diagnosis of pheochromocytoma using [123I]-compared with [131I]-metaiodobenzylguanidine scintigraphy

1 reference

12 December 2020

123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma.

1 reference

12 December 2020

(123)I- or (125)I-metaiodobenzylguanidine visualization of brown adipose tissue

1 reference

12 December 2020

Metastatic neuroblastoma in children older than one year: prognostic significance of the initial metaiodobenzylguanidine scan and proposal for a scoring system.

1 reference

12 December 2020

Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours.

1 reference

12 December 2020

Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma

1 reference

12 December 2020

A new 123I-MIBG whole body scan scoring method--application to the prediction of the response of metastases to induction chemotherapy in stage IV neuroblastoma

1 reference

12 December 2020

The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy

1 reference

12 December 2020

10.1007/S00259-010-1545-7

Identifiers

DOI

1 reference

11 November 2017

1 reference